These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2414097)

  • 1. A case of ruptured hepatoma followed by elastase-induced disseminated intravascular coagulation.
    Takasugi S; Nishiki M; Kanao M; Okumichi T; Ezaki H; Toki N
    Enzyme; 1985; 33(3):147-52. PubMed ID: 2414097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis.
    Toki N; Takasugi S; Sumi H
    Clin Sci (Lond); 1982 Mar; 62(3):321-8. PubMed ID: 6174264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
    Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
    [No Abstract]   [Full Text] [Related]  

  • 7. Mini-plasminogen like molecule in septic patients.
    Kordich LC; Porterie VP; Lago O; Bergonzelli GE; Sassetti B; Sanchez Avalos JC
    Thromb Res; 1987 Sep; 47(5):553-60. PubMed ID: 2445046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies of serum protease inhibitors in hepatoma].
    Kageyama T; Tsumoto S; Oyabu H
    Gan No Rinsho; 1983 Feb; 29(2):A-7, 115-9. PubMed ID: 6308300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolysis and disseminated intravascular coagulation].
    Ikematsu S
    Rinsho Byori; 1985 Jun; Spec No 63():27-36. PubMed ID: 2931536
    [No Abstract]   [Full Text] [Related]  

  • 12. An elastase-dependent pathway of plasminogen activation.
    Machovich R; Owen WG
    Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective determination of alpha 2-plasmin inhibitor activity in plasma using chromogenic substrate.
    Matsuda T; Ogawara M; Miura R; Seki T; Matsumoto T; Teramura Y; Nakamura K
    Thromb Res; 1984 Feb; 33(4):379-88. PubMed ID: 6200949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of alpha 2-plasmin inhibitor in patients with gastric cancer.
    Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
    Bull Osaka Med Sch; 1984 Oct; 30(2):89-95. PubMed ID: 6571385
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN; Cercek B; Lew AS; Ganz W
    Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique elastase in human blood platelets.
    James HL; Wachtfogel YT; James PL; Zimmerman M; Colman RW; Cohen AB
    J Clin Invest; 1985 Dec; 76(6):2330-7. PubMed ID: 2416778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
    Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.